Periocular skin cancer: Diagnosis and management.
Adenocarcinoma, Sebaceous
/ diagnosis
Antineoplastic Agents
/ therapeutic use
Antineoplastic Agents, Immunological
/ therapeutic use
Bowen's Disease
/ diagnosis
Carcinoma, Basal Cell
/ diagnosis
Carcinoma, Merkel Cell
/ diagnosis
Carcinoma, Squamous Cell
/ diagnosis
Dermatologic Surgical Procedures
Eyelid Neoplasms
/ diagnosis
Head and Neck Neoplasms
/ diagnosis
Humans
Keratosis, Actinic
/ diagnosis
Melanoma
/ diagnosis
Mohs Surgery
Neoplasms, Adnexal and Skin Appendage
/ diagnosis
Sebaceous Gland Neoplasms
/ diagnosis
Skin Neoplasms
/ diagnosis
Basal cell carcinoma
Melanoma
Merkel cell carcinoma
Periocular malignancies
Periocular skin cancer
Sebaceous carcinoma
Squamous cell carcinoma
microcystic adnexal carcinoma
Journal
Disease-a-month : DM
ISSN: 1557-8194
Titre abrégé: Dis Mon
Pays: United States
ID NLM: 0370657
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
pubmed:
1
7
2020
medline:
15
12
2020
entrez:
1
7
2020
Statut:
ppublish
Résumé
The periocular region sees high rates of cancer compared to the rest of the body and can be affected by several unique tumors. Treatment typically involves surgical excision, although adjunctive therapies and prognosis vary depending on the diagnosis. Basal cell carcinoma (BCC) is the most common malignancy affecting this region and should be excised promptly. This is followed by squamous cell carcinoma, which is often mistaken for BCC but is treated similarly. Melanoma is less common but more deadly, with relatively high rates of metastasis and death. Rare tumors that may be found in this region include sebaceous carcinoma, Merkel cell carcinoma, and microcystic adnexal carcinoma. While uncommon, these tumors are associated with poor outcomes and frequent recurrence. Recognition of periocular skin cancer is an important skill for primary care physicians, as prompt diagnosis and treatment can be sight or life-saving.
Identifiants
pubmed: 32600650
pii: S0011-5029(20)30108-5
doi: 10.1016/j.disamonth.2020.101046
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Antineoplastic Agents, Immunological
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101046Informations de copyright
Copyright © 2020. Published by Elsevier Inc.